Fineotex Chemical Share Price Today

Fineotex Chemical incorporates US subsidiary for data center solutions

Incorporated Fineotex America Inc. in Delaware, USA, on September 24, 2026. Targeting water treatment solutions for data centers and semiconductor manufacturing. Entity is a wholly owned step-down subsidiary of Fineotex Biotex HealthGuard FZE. Current turnover reported as nil; no acquisition cost or consideration involved.

Fineotex Chemical to host analyst call on September 28

Fineotex Chemical Ltd to host virtual analyst call on September 28, 2026. Event is part of Arihant Bharat Connect Virtual Conference at 2:00 pm IST. Management confirms no unpublished price sensitive information will be shared. Disclosure made under Regulation 30 of SEBI LODR Regulations, 2015.

Fineotex Chemical shareholders approve dividend, fund raise at AGM

Shareholders approved FY26 audited financials and final dividend declaration. Special resolution passed to raise funds via equity share issuance. Executive Director Aarti Jhunjhunwala re-appointed by rotation. Auditor report contained no qualifications or adverse remarks.

Fineotex Chemical hosts investor plant visit in Ambernath on Sep 11

Fineotex Chemical hosts plant visit on September 11, 2026. Event held at Ambernath facility in Maharashtra. Fourteen firms including Electrum Capital attend. No price-sensitive information to be disclosed.

Fineotex Chemical forms step-down subsidiary in Delaware, USA

Fineotex Chemical's subsidiary Fineotex Biotex Healthguard FZE has incorporated Fineotex Holdings Inc. in Delaware, USA. Fineotex Holdings Inc. is a wholly owned step-down subsidiary of Fineotex Chemical. The new entity is established to explore specialty chemicals and other growth opportunities. The incorporation expands Fineotex Chemical's international corporate structure through its existing overseas subsidiary.

Fineotex Chemical files revised FY26 annual report with typographical correction

Fineotex Chemical Limited filed a revised FY26 Annual Report on August 18, 2026, correcting an inadvertent typographical error with no changes to financial results or material information. The 23rd AGM remains scheduled for September 11, 2026, where shareholders will consider raising up to ₹800 crore, approving related party transactions of up to ₹500 crore, and other business. Consolidated revenue for FY26 rose 44.79% to ₹77,222.56 lakhs and PAT grew 14.50% to ₹12,501.51 lakhs, with ICRA reaffirming ratings at ICRA A+ (Positive) and ICRA A1+.